Clinical Trial Update: Phase 2 Study of DKN-01 in Colorectal Cancer [Phase 2]

View source ↗

Summary

Leap Therapeutics’ DKN-01 Phase 2 study in colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• DKN-01 (dkn-01)

Snippet

Sponsor: Leap Therapeutics, Inc. | Conditions: Colorectal Cancer, Colorectal Adenocarcinoma | Phase 2 | Status: COMPLETED